Transgene and Jenner begin liver cancer trial for enclitic therapy
This article was originally published in Scrip
Executive Summary
Transgene and Jennerex have initiated a Phase IIb trial investigating its oncolytic therapy, JX594 (also TG6006) in liver cancer, in line with plans announced earlier in the year.